MeSH tree: C01.925.440
A University of Houston College of Pharmacy professor has published two studies offering a comprehensive look at chronic liver disease in the era of modern antiviral therapies. One study is the first analysis of its economic ...
Apr 29, 2026
0
5
Millions of people worldwide carry viral infections they acquired at birth, often for life. For a long time it was assumed that the immune system hardly fights these pathogens. Researchers from the University of Basel show ...
Apr 28, 2026
0
9
Delaying hepatitis B vaccination after birth increases infections among newborns and decreases their survival rates and quality of life, according to a new Cornell University study. The longer the delay, the study found, ...
Apr 27, 2026
0
15
Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, including chronic liver disease. Despite longstanding recommendations for prenatal screening, an estimated ...
Apr 27, 2026
0
7
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to emerge in an advanced stage of disease that turns to fatal cirrhosis or liver cancer in nearly a million ...
Apr 22, 2026
0
6
It took less than 22 years after the discovery of the hepatitis C virus (HCV) for a fast-acting, highly effective treatment to become available. Modern drugs are more than 95% effective at curing hepatitis C infection, yet ...
Apr 20, 2026
0
5
Chronic hepatitis B is substantially prevalent across the European Union and European Economic Area (EU/EEA), affecting an estimated 0.7% of the population in the region in 2022, according to a new study published in Eurosurveillance. ...
Apr 13, 2026
0
1
A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject drugs, potentially providing a major boost to lagging U.S. efforts to meet national hepatitis C elimination ...
Mar 30, 2026
0
4
Direct-acting antivirals (DAAs) can cure hepatitis C (HCV) in more than 95% of individuals treated. But only 1 in 3 people with HCV in the U.S. receive treatment within a year of diagnosis. A new study by investigators from ...
Mar 25, 2026
0
3
A recently released prospective analysis of the first eight years of the Johns Hopkins Medicine-led Zero TB in Kids program shows that significant reduction of tuberculosis (TB) transmission and burden (the total impact of ...
Mar 24, 2026
0
3
